Search Results 981-990 of 18210 for Hepatitis C

  1. DALY 2.0 USA/​ MB-CART2019.1 for DLBCL - Mayo Clinic

    ... hepatitis B (HBsAg positive). If there is a history of treated hepatitis B or hepatitis C, the viral load must be quantitative polymerase chain reaction ...

  2. Publications - Stephanie C. Mavis, M.D., M.H.P.E. - Mayo Clinic

    Collura CA, Brumbaugh JE, Misgen MM, Stetson RC, Mavis SC, Omdahl TK, Reeve CE, Colby CE. Novel approach to improving teamwork in healthcare. BMJ Lead.

  3. News - Fernando C. Fervenza, M.D., Ph.D. - Mayo Clinic

    Fernando C. Fervenza, M.D., Ph.D. Nephrologist. Request an Appointment · Overview · News. News. Print. 2023. Mayo Clinic Proceedings, Kidney International ...

  4. A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy - Mayo Clinic

    Participation eligibility · Documentation of HBsAg, hepatitis B surface antibody (HBsAb), hepatitis B core antibody (HBcAb), and hepatitis C virus (HCV) antibody ...

  5. A Study To Assess The Efficacy And Safety Of Induction And Maintenance Therapy With Afimkibart (RO7790121) In Participants With Moderately To Severely Active Crohn's Disease - Mayo Clinic

    ... Hepatitis B (HBV), Hepatitis C (HCV) during screening * Has evidence of active tuberculosis (TB), latent TB not successfully treated (per local guidance) or ...

  6. Publications - John C. Schupbach, M.D., M.B.A. - Mayo Clinic

    Morey J, Schupbach J, Jones D, Walker L, Lindor R, Loufek B, Mullan A, Cabrera D. FDA-reviewed artificial intelligence-enabled products applicable to ...

  7. Mayo Clinic Q and A: Safeguarding the blood supply

    If you don't have hepatitis B, it's likely you will be able to donate blood again. In the U.S., the U.S. Food and Drug Administration requires blood donation ...

  8. Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma (KarMMa) - Mayo Clinic

    Seropositive for and with active viral infection with hepatitis C virus (HCV):. Subjects who had hepatitis C but have received an antiviral treatment and show ...

  9. A Study to Evaluate Outpatient Blinatumomab in Subjects with Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL) - Mayo Clinic

    Known infection or chronic infection with hepatitis B virus (hepatitis B surface antigen. [HBsAg] positive) or hepatitis C virus (HCV) (anti-HCV positive).

  10. Publications - Wisit Cheungpasitporn, M.D. - Mayo Clinic

    Arriola-Montenegro J, Cheungpasitporn W, Thongprayoon C, Craici IM, Miao J. Public interest in chronic kidney disease and dialysis: a 20-year data analysis.